JP2016520112A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520112A5
JP2016520112A5 JP2016516184A JP2016516184A JP2016520112A5 JP 2016520112 A5 JP2016520112 A5 JP 2016520112A5 JP 2016516184 A JP2016516184 A JP 2016516184A JP 2016516184 A JP2016516184 A JP 2016516184A JP 2016520112 A5 JP2016520112 A5 JP 2016520112A5
Authority
JP
Japan
Prior art keywords
compound
antidepressant
reuptake inhibitor
composition
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016516184A
Other languages
English (en)
Japanese (ja)
Other versions
JP6415545B2 (ja
JP2016520112A (ja
Filing date
Publication date
Priority claimed from EP13169936.5A external-priority patent/EP2808023A1/en
Application filed filed Critical
Publication of JP2016520112A publication Critical patent/JP2016520112A/ja
Publication of JP2016520112A5 publication Critical patent/JP2016520112A5/ja
Application granted granted Critical
Publication of JP6415545B2 publication Critical patent/JP6415545B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016516184A 2013-05-30 2014-05-30 抑うつ障害の治療用及び/又は予防用の新規薬剤 Expired - Fee Related JP6415545B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13169936.5 2013-05-30
EP13169936.5A EP2808023A1 (en) 2013-05-30 2013-05-30 New drug for the treatment and/or prevention of depressive disorders
PCT/EP2014/061240 WO2014191547A1 (en) 2013-05-30 2014-05-30 New drug for the treatment and/or prevention of depressive disorders

Publications (3)

Publication Number Publication Date
JP2016520112A JP2016520112A (ja) 2016-07-11
JP2016520112A5 true JP2016520112A5 (cg-RX-API-DMAC7.html) 2017-04-20
JP6415545B2 JP6415545B2 (ja) 2018-10-31

Family

ID=48520808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016516184A Expired - Fee Related JP6415545B2 (ja) 2013-05-30 2014-05-30 抑うつ障害の治療用及び/又は予防用の新規薬剤

Country Status (5)

Country Link
US (2) US20160067231A1 (cg-RX-API-DMAC7.html)
EP (2) EP2808023A1 (cg-RX-API-DMAC7.html)
JP (1) JP6415545B2 (cg-RX-API-DMAC7.html)
CA (1) CA2910530A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014191547A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6715568B2 (ja) * 2015-01-22 2020-07-01 公益財団法人東京都医学総合研究所 睡眠異常をきたすうつ病のモデル動物
AU2018371628B2 (en) * 2017-11-22 2021-08-12 Excelsior Pharmatech Labs Benzoic acid or a salt and derivative thereof for use in preventing or treating depression
CN116870180B (zh) * 2023-08-08 2026-04-21 中南大学湘雅医院 一种递送神经递质的纳米制剂及其制备方法与应用
CN117904008B (zh) * 2024-03-19 2024-06-11 山东中科嘉亿生物工程有限公司 一种预防和缓解抑郁的戊糖片球菌jypr-9187及其菌剂和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1243101A (en) * 1999-10-28 2001-05-08 Cary Pharmaceuticals Inc. High dose folic acid for the treatment of hyperhomocysteinemia
US7758872B1 (en) * 2003-02-07 2010-07-20 Eric Finzi Method of treating depression
SI1631557T1 (sl) * 2003-06-12 2007-06-30 Btg Int Ltd Cikličen hidroksilamin kot psihoaktivne spojine
US20060039890A1 (en) * 2004-08-20 2006-02-23 Renshaw Perry F Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
RU2540470C9 (ru) * 2008-06-06 2015-07-20 Фарма Ту Б Лтд. Фармацевтические композиции для лечения болезни паркинсона
US8778969B2 (en) 2009-11-07 2014-07-15 Peter H Proctor Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines

Similar Documents

Publication Publication Date Title
JOP20220069A1 (ar) عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها
CN101861151B (zh) 使用组蛋白脱乙酰基酶hdac1、hdac2和/或hdac3的选择性抑制剂和微管稳定剂的癌症组合治疗
JP2017509686A5 (cg-RX-API-DMAC7.html)
RU2013108696A (ru) ПРОИЗВОДНЫЕ ЦИС-ТЕТРАГИДРО-СПИРО(ЦИКЛОГЕСАН -1,1'-ПИРИДО[3,4-b]ИНДОЛ)-4-АМИНА
EP1858516A1 (en) Pharmaceutical compositions for the treatment and/or prevention of depression
JP2011523949A5 (cg-RX-API-DMAC7.html)
DE602006021444D1 (de) Therapie zur behandlung der überaktiven blase
JP2015511609A5 (cg-RX-API-DMAC7.html)
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
BRPI0610037A2 (pt) derivados de dihidrobenzofurano e uso dos mesmos
JP2017531689A5 (cg-RX-API-DMAC7.html)
RU2017106172A (ru) Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn)
CN114072404A (zh) Ret选择性抑制剂及其制备方法和用途
WO2006130679B1 (en) Composition and method for the treatment of allergic rhinitis
TW200736189A (en) Indene derivatives, their preparation and use as medicaments
RU2010154417A (ru) Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств
US6562858B2 (en) Method for treating depression
JP2020511437A5 (cg-RX-API-DMAC7.html)
JP2019085364A5 (cg-RX-API-DMAC7.html)
EP3858351A1 (en) Pharmaceutical composition for treating fibrosis
JP2018508556A5 (cg-RX-API-DMAC7.html)
JP2020502106A5 (cg-RX-API-DMAC7.html)
Sharma et al. Inhibitors of transcription factor nuclear factor-kappa beta (NF-κβ)-DNA binding
JP2012526793A5 (cg-RX-API-DMAC7.html)
JP2021519330A5 (cg-RX-API-DMAC7.html)